Trial Profile

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PXS-5382A (Primary)
Indications Idiopathic pulmonary fibrosis; Non-alcoholic steatohepatitis; Renal fibrosis
Focus Pharmacokinetics
Sponsors Pharmaxis; Syntara Limited

Most Recent Events

04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited
24 Jun 2020 Status changed from active, no longer recruiting to completed.
02 Mar 2020 Status changed to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com